iBio Inc (IBIO)
1.71
+0.05
(+3.01%)
USD |
NYAM |
Apr 30, 16:00
1.68
-0.03
(-1.75%)
After-Hours: 20:00
iBio Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.07M |
| December 31, 2022 | 0.97M |
| September 30, 2022 | 1.055M |
| June 30, 2022 | 1.00M |
| March 31, 2022 | 1.004M |
| December 31, 2021 | 0.111M |
| September 30, 2021 | 0.207M |
| June 30, 2021 | 0.426M |
| March 31, 2021 | 0.387M |
| December 31, 2020 | 0.18M |
| September 30, 2020 | 0.30M |
| June 30, 2020 | 0.075M |
| March 31, 2020 | 0.075M |
| December 31, 2019 | 0.224M |
| September 30, 2019 | 0.075M |
| June 30, 2019 | 0.097M |
| March 31, 2019 | 0.117M |
| December 31, 2018 | 0.155M |
| September 30, 2018 | 0.119M |
| June 30, 2018 | 0.075M |
| March 31, 2018 | 0.181M |
| December 31, 2017 | 0.136M |
| September 30, 2017 | 0.26M |
| June 30, 2017 | 0.175M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.128M |
| December 31, 2016 | 0.025M |
| September 30, 2016 | 0.17M |
| June 30, 2016 | 0.484M |
| March 31, 2016 | 0.454M |
| December 31, 2015 | 0.202M |
| September 30, 2015 | 0.48M |
| June 30, 2015 | 0.445M |
| March 31, 2015 | 0.341M |
| December 31, 2014 | 0.584M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.205M |
| March 31, 2014 | 1.007M |
| December 31, 2013 | 1.007M |
| September 30, 2013 | 1.007M |
| June 30, 2013 | 1.007M |
| March 31, 2013 | 0.3902M |
| December 31, 2012 | 0.3902M |
| September 30, 2012 | 0.3902M |
| June 30, 2012 | 0.351M |
| March 31, 2012 | 0.3718M |
| December 31, 2011 | 0.2338M |
| September 30, 2011 | 0.3203M |
| June 30, 2011 | 0.3441M |
| March 31, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2023
1.055M
Maximum
Sep 2022
0.368M
Average
0.207M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
| Lixte Biotechnology Holdings Inc | -- |
| PAVmed Inc | 0.061M |
| Avalo Therapeutics Inc | -- |
| Imunon Inc | -- |
| Ocugen Inc | -- |